Skip to main content

Table 3 Percentage of neoadjuvant and adjuvant therapy performed in each time period over all patients

From: Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades

Therapy all patients 1993-2001 (n=301) 2002. 2010 (n=357) p-value
No. % No. %
Neoadjuvant      
No 248 82.4 143 40 <0.001
Chemo 1 0.3 3 0.8 n.s.
Radio 36 12 83 23.3 0.011
Radiochemo 16 5.3 126 35.3 <0.001
Unknown 0 0 2 0.6 n.s.
Adjuvant      
No 187 62.1 149 41.6 <0.001
Chemo 48 16 162 45.3 <0.001
Radio 19 6.3 8 2.2 0.009
Radiochemo 33 11 20 5.9 0.02
Unknown 14 4.7 18 5.0 n.s.